'We need to show up with evidence': Edwards Lifesciences CEO

'We need to show up with evidence': Edwards Lifesciences CEO-modernhealthcare: Worldwide sales in the first three quarters of 2014 were $1.7 billion, up 12.9% from the same period the previous year. In December, Edwards announced an agreement for the exclusive right to purchase CardioKinetix, which is developing an implantable device to treat heart failure. Before joining Edwards, Mussallem was a senior executive at Baxter International. He serves on the executive committee of the Advanced Medical Technology Association and the executive committee of the Healthcare Leadership Council. Modern Healthcare reporter Jaimy Lee spoke with Mussallem about Edwards' plans, how his firm demonstrates the value of its products to health systems, and the prospects for repeal of the medical-device tax.